Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3.6000
+0.0400
+(1.12%)
As of 9:10:05 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-74,748
-67,390
-49,109
-41,827
-29,809
Investing Cash Flow
129,170
-37,987
-22,272
-119,696
6,693
Financing Cash Flow
177,553
41,951
167,095
134,393
85,515
End Cash Position
269,868
79,926
143,235
47,699
74,854
Income Tax Paid Supplemental Data
--
28
3
238
178
Capital Expenditure
-86
-52
-275
-340
-584
Issuance of Capital Stock
175,999
41,611
167,253
136,362
69,377
Issuance of Debt
--
--
--
--
16,876
Repayment of Debt
--
--
--
-12,880
--
Free Cash Flow
-74,834
-67,442
-49,384
-42,167
-30,393
12/31/2020 - 8/17/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NICXF Nicox S.A.
0.2400
0.00%
ANL Adlai Nortye Ltd.
2.2203
+0.92%
TRDA Entrada Therapeutics, Inc.
12.02
-0.83%
CGEM Cullinan Therapeutics, Inc.
8.45
-1.29%
IMCR Immunocore Holdings plc
30.77
+5.34%
IMTX Immatics N.V.
4.2500
-2.97%
MNPR Monopar Therapeutics Inc.
31.29
+0.58%
PTGX Protagonist Therapeutics, Inc.
36.15
+3.02%
AGIO Agios Pharmaceuticals, Inc.
34.44
-2.13%
VNDA Vanda Pharmaceuticals Inc.
4.7100
+5.61%